Fund profile
Tickers
IHE
Fund manager
Total assets
$652.41 mm
Liabilities
$22.40 mm
Net assets
$630.02 mm
Number of holdings
36.00
IHE stock data
36 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 135.39 mm | 863.76 k shares | 21.49 | Common equity | Long | USA |
LLY Eli Lilly and Company | 133.84 mm | 229.60 k shares | 21.24 | Common equity | Long | USA |
VTRS Viatris Inc. | 30.25 mm | 2.79 mm shares | 4.80 | Common equity | Long | USA |
ZTS Zoetis Inc. | 29.35 mm | 148.72 k shares | 4.66 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 27.94 mm | 256.25 k shares | 4.43 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 27.84 mm | 542.51 k shares | 4.42 | Common equity | Long | USA |
PFE Pfizer Inc. | 27.05 mm | 939.53 k shares | 4.29 | Common equity | Long | USA |
RPRX Royalty Pharma plc | 26.43 mm | 941.08 k shares | 4.20 | Common equity | Long | UK |
CTLT Catalent, Inc. | 23.63 mm | 525.84 k shares | 3.75 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 22.60 mm | 183.73 k shares | 3.59 | Common equity | Long | Ireland |
BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | 22.18 mm | 22.16 mm shares | 3.52 | Short-term investment vehicle | Long | USA |
ELAN Elanco Animal Health Incorporated | 21.42 mm | 1.44 mm shares | 3.40 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 18.70 mm | 261.13 k shares | 2.97 | Common equity | Long | USA |
PRGO Perrigo Company plc | 12.73 mm | 395.66 k shares | 2.02 | Common equity | Long | Ireland |
OGN Organon & Co. | 10.75 mm | 745.72 k shares | 1.71 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 9.01 mm | 113.18 k shares | 1.43 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc. | 8.87 mm | 144.93 k shares | 1.41 | Common equity | Long | USA |
CORT Corcept Therapeutics Incorporated | 8.56 mm | 263.43 k shares | 1.36 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 7.43 mm | 314.51 k shares | 1.18 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 6.75 mm | 109.20 k shares | 1.07 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 6.60 mm | 160.47 k shares | 1.05 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 4.62 mm | 159.59 k shares | 0.73 | Common equity | Long | USA |
PCRX Pacira BioSciences, Inc. | 4.58 mm | 135.70 k shares | 0.73 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 3.42 mm | 47.95 k shares | 0.54 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 3.09 mm | 95.72 k shares | 0.49 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 2.75 mm | 152.02 k shares | 0.44 | Common equity | Long | USA |
INVA Innoviva, Inc. | 2.65 mm | 165.28 k shares | 0.42 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 2.64 mm | 85.86 k shares | 0.42 | Common equity | Long | USA |
SAVA Cassava Sciences, Inc. | 2.60 mm | 115.62 k shares | 0.41 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals, Inc. | 2.44 mm | 44.21 k shares | 0.39 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 2.25 mm | 255.99 k shares | 0.36 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 1.75 mm | 118.55 k shares | 0.28 | Common equity | Long | USA |
TBPH Theravance Biopharma, Inc. | 1.14 mm | 101.13 k shares | 0.18 | Common equity | Long | Cayman Islands |
BLACKROCK CASH FUNDS TREASURY | 748.65 k | 748.65 k shares | 0.12 | Short-term investment vehicle | Long | USA |
XAV HEALTH CARE MAR24 | 20.69 k | 5.00 contracts | 0.00 | Equity derivative | N/A | USA |
CASSAVA SCIENCES INC | 0.46 | 45.56 k shares | 0.00 | Equity derivative | N/A | USA |